Vieira Sells Acadia Pharmaceuticals on Buyout News after calling a bottom for 2016 on shares of the American biotech company.
Acadia Pharmaceuticals (ACAD) become the best biotech stock market performer on his upgrade ahead of FDA approval and buyout rumors.
If you buy shares of any company when Americans are collapsing in the market you will make a vast fortune since they will aways come back later on to buy at much higher prices.
Vieira who often calls the absolute top and bottom in stocks on live streaming, urged investors to close their large short positions on Acadia (ACAD) in March 2016 at a price of $17.3
He was a former bear calling a crash on Acadia issuing the most bearish live market call on Acadia Pharmaceuticals (ACAD) downgrading this biotech company to Junk within the range $48-52, predicting a collapse.
Not only he has the best track record in the world trading biotech stocks as he is the only investor in the world who has been able to accurately predict Acadia (ACAD) trend reversals.
We’re offering millions of dollars in profits to any investor for free, complimentary live trade cals available worldwide, risk free backed up the 100% money back guarantee. I would like to congratulate Acadia Pharmaceuticals (ACAD) investors. The profit obtained during the crash added to the recent one proves that we have the world’s best live track record in the markets. Forget about the rest, most market participants are scammers losing money in the markets whose aim is to deceive you.
A truly loser is one that has access to what he has to do to make millions of dollars, yet chooses not to since he was born to lose money consistently by following crooks.
What investors should do now?
Vieira is a wonderful person! He left the bulk of profits for long term investors who are willing to stay invested in the coming buyout announced on the media.